Nutex Health, Inc.
For the period ended Sep 30, 2025. Filed Nov 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 19, 2025
NUTX$194.16+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
| (In thousands, except share and per share amounts) | September 30, 2025 | December 31, 2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $166,048 | $40,640 |
| Restricted short-term investments | — | 2,941 |
| Accounts receivable | 387,409 | 232,449 |
| Accounts receivable - related parties | 7,353 | 3,602 |
| Inventories | 3,158 | 2,850 |
| Income tax receivable | 12,097 | — |
| Prepaid expenses and other current assets | 16,586 | 9,997 |
| Total current assets | 592,651 | 292,479 |
| Property and equipment, net | 82,821 | 77,933 |
| Operating lease right-of-use assets | 27,354 | 27,872 |
| Financing lease right-of-use assets | 225,719 | 218,889 |
| Intangible assets, net | 21,555 | 15,530 |
| Goodwill, net | 13,919 | 13,919 |
| Deferred tax assets | — | 7,987 |
| Other assets | 499 | 711 |
| Total assets | $964,518 | $655,320 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Accounts payable | $45,475 | $9,614 |
| Accounts payable - related parties | 4,082 | 806 |
| Lines of credit | 5,304 | 3,554 |
| Current portion of long-term debt | 18,004 | 14,395 |
| Operating lease liabilities, current portion | 2,111 | 2,080 |
| Financing lease liabilities, current portion | 7,108 | 7,705 |
| Accrued arbitration expenses | 64,313 | 47,742 |
| Accrued income tax expense | — | 26,533 |
| Accrued stock-based compensation | 11,194 | 16,356 |
| Accrued expenses and other current liabilities | 27,865 | 25,440 |
| Total current liabilities | 185,456 | 154,225 |
| Long-term debt, net | 25,574 | 22,466 |
| Operating lease liabilities, net | 30,423 | 30,617 |
| Financing lease liabilities, net | 270,077 | 259,479 |
| Deferred tax liabilities | 14,955 | — |
| Total liabilities | 526,485 | 466,787 |
| Commitments and contingencies (Note 10) | ||
| Equity: | ||
| Common stock, $0.001 par value; 950,000,000 shares authorized; 6,905,262 and 5,511,452 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 7 | 6 |
| Additional paid-in capital | 615,180 | 489,409 |
| Accumulated deficit | (298,021) | (356,976) |
| Nutex Health Inc. equity | 317,166 | 132,439 |
| Noncontrolling interests | 120,867 | 56,094 |
| Total equity | 438,033 | 188,533 |
| Total liabilities and equity | $964,518 | $655,320 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.